These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 17071802)

  • 1. Demyelinating diseases.
    Love S
    J Clin Pathol; 2006 Nov; 59(11):1151-9. PubMed ID: 17071802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis.
    Young NP; Weinshenker BG; Parisi JE; Scheithauer B; Giannini C; Roemer SF; Thomsen KM; Mandrekar JN; Erickson BJ; Lucchinetti CF
    Brain; 2010 Feb; 133(Pt 2):333-48. PubMed ID: 20129932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive subpial cortical demyelination is specific to multiple sclerosis.
    Junker A; Wozniak J; Voigt D; Scheidt U; Antel J; Wegner C; Brück W; Stadelmann C
    Brain Pathol; 2020 May; 30(3):641-652. PubMed ID: 31916298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging evaluation of demyelinating processes of the central nervous system.
    Smith AB; Smirniotopoulos JG
    Postgrad Med J; 2010 Apr; 86(1014):218-29. PubMed ID: 20354045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmotic demyelination syndromes: central and extrapontine myelinolysis.
    Huq S; Wong M; Chan H; Crimmins D
    J Clin Neurosci; 2007 Jul; 14(7):684-8. PubMed ID: 17462902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the ground substance on the extracellular water of normal and edematous human brain: focal edema and the demyelinating diseases, including multiple sclerosis.
    Feigin I; Budzilovich GN
    J Neuropathol Exp Neurol; 1980 Jan; 39(1):13-29. PubMed ID: 7359171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis.
    Brown WD
    Curr Opin Neurol; 2000 Dec; 13(6):691-7. PubMed ID: 11148672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical demyelination in PML and MS: similarities and differences.
    Savolainen H
    Neurology; 2009 Mar; 72(9):861. PubMed ID: 19255419
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of so-called demyelinating encephalitis.
    Oppenheimer DR
    Neuropatol Pol; 1966; 4():Suppl:717-21. PubMed ID: 4389366
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-multiple sclerosis recurrent demyelinating disorders: an ongoing debate.
    Marchioni E; Tavazzi E; Bastianello S
    Brain; 2010 Aug; 133(Pt 8):e150; author reply e151. PubMed ID: 20435629
    [No Abstract]   [Full Text] [Related]  

  • 11. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases.
    Gendelman HE; Pezeshkpour GH; Pressman NJ; Wolinsky JS; Quarles RH; Dobersen MJ; Trapp BD; Kitt CA; Aksamit A; Johnson RT
    Ann Neurol; 1985 Sep; 18(3):324-8. PubMed ID: 2413798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory demyelinating polyradiculitis in a patient with acute disseminated encephalomyelitis (ADEM).
    Kinoshita A; Hayashi M; Miyamoto K; Oda M; Tanabe H
    J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):87-90. PubMed ID: 8558159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
    Koshihara H; Oguchi K; Takei Y; Kitazawa K; Higuchi K; Ohara S
    J Neurol Sci; 2014 Nov; 346(1-2):323-7. PubMed ID: 25216555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of acute disseminated encephalomyelitis with pathologically-proven acute demyelinating lesion in the peripheral nervous system].
    Kinoshita A; Kaseda S; Yagi K; Oda M; Tanabe H
    Rinsho Shinkeigaku; 1994 Sep; 34(9):892-7. PubMed ID: 7820963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of axonal damage in human acute demyelinating diseases.
    Ghosh N; DeLuca GC; Esiri MM
    J Neurol Sci; 2004 Jul; 222(1-2):29-34. PubMed ID: 15240192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions.
    Dale RC; Pillai SC
    Dev Med Child Neurol; 2007 Dec; 49(12):887-93. PubMed ID: 18039234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute paraplegia with vanishing white matter lesions.
    Jensen RM; Kinkel RP
    Rev Neurol Dis; 2008; 5(3):159-60; discussion 164-6. PubMed ID: 18838956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of multiple sclerosis: contribution of magnetic resonance techniques.
    Triulzi F; Scotti G
    J Neurol Neurosurg Psychiatry; 1998 May; 64 Suppl 1():S6-14. PubMed ID: 9647278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filamentous and multilamellated cytoplasmic inclusions in progressive multifocal leukoencephalopathy.
    Hauw JJ; Esourolle R
    Acta Neuropathol; 1977 Mar; 37(3):263-5. PubMed ID: 193344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical demyelination in CNS inflammatory demyelinating diseases.
    Lassmann H; Lucchinetti CF
    Neurology; 2008 Jan; 70(5):332-3. PubMed ID: 18227414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.